Medicana Health Group, a global leader in integrated healthcare services, is making a significant leap into the UK market to cater to the surging demand for superior healthcare services.
As a trailblazer in holistic healthcare delivery, Medicana Health Group is set to broaden its horizons into the UK, bringing its patient-centric model and tailored healthcare solutions. This strategic venture is a response to the increasing reliance on private healthcare and insurance solutions in the aftermath of COVID. Medicana prides itself on its dedication to “active listening and personalised attention,” a principle that drives its efforts to understand and fulfil the unique requirements of each patient, promising a healthcare journey that is customised from the outset to aftercare, thus aiming to revolutionise the standards of private healthcare in the UK.
Adhering to its ethos of “active listening and personalised attention at every stage of the patient’s journey,” Medicana Health Group aspires to deliver a patient experience that is not only deeply personal but also meticulously crafted, replicating their successful approach in Türkiye to effect a significant transformation in the UK’s private healthcare landscape.
Penetrating the £282 Billion UK Healthcare Market
In the wake of the COVID-19 pandemic, the UK’s private healthcare sector has witnessed a significant revival, largely propelled by an increase in self-funding patients. A growing number of individuals are opting for private healthcare to avoid the lengthy wait times associated with the NHS and to access the high-quality services and expertise of the independent sector. The Akeso report indicates that the UK’s total healthcare spending in 2022 was estimated at £282 billion, with approximately 80% coming from public funding and 20% from private sources.
Seizing this opportunity, Medicana is poised to bring its vast expertise and comprehensive array of care services to the UK’s burgeoning private healthcare market. By deploying its proven model of care, which spans from advanced diagnostics to specialised treatments, Medicana is well-prepared to address the increasing demand for high-calibre private healthcare. The group’s relentless pursuit of excellence, along with its innovative approach to patient care, makes Medicana a compelling choice for meeting the UK’s healthcare challenges.
Catering to 5.5 Million Patients Yearly
Medicana Health Group annually provides top-notch healthcare to over 5.5 million patients globally, utilising its network of 16 hospitals with extensive bed capacities. This showcases their extensive experience in offering premium care and their capability to meet the varied needs of a global patient population. The entry of Medicana Health Group into the UK market is anticipated to bring about a significant shift towards more compassionate, efficient, and individualised healthcare, marking a new era in their commitment to elevating patient care and global healthcare standards.
With a legacy of over 30 years, Medicana’s expertise spans numerous medical specialties, offering state-of-the-art services in areas such as Oncology, Surgical Oncology, Organ and Bone Marrow Transplantation, Neurosurgery, In Vitro Fertilisation (IVF), Genetics, Cardiovascular Surgery, Orthopaedics and Traumatology, and Obesity Surgery. Furthermore, since 2016, Medicana Health Group has expanded its educational initiatives, providing a broad spectrum of educational programs from preschool to university level, both within Türkiye and internationally.
